Publications

Found 15 results
Filters: Keyword is Cells, Cultured  [Clear All Filters]
2017
Schenck, S., Kunz L., Sahlender D., Pardon E., Geertsma E. R., Savtchouk I., Suzuki T., Neldner Y., Štefanić S., Steyaert J., et al., "Generation and Characterization of Anti-VGLUT Nanobodies Acting as Inhibitors of Transport.", Biochemistry, vol. 56, issue 30, pp. 3962-3971, 2017 08 01.
2016
Peyrassol, X., Laeremans T., Gouwy M., Lahura V., Debulpaep M., Van Damme J., Steyaert J., Parmentier M., and Langer I., "Development by Genetic Immunization of Monovalent Antibodies (Nanobodies) Behaving as Antagonists of the Human ChemR23 Receptor.", J Immunol, vol. 196, issue 6, pp. 2893-901, 2016 Mar 15.
2014
Qiao, W., Wang W., Laurenti E., Turinsky A. L., Wodak S. J., Bader G. D., Dick J. E., and Zandstra P. W., "Intercellular network structure and regulatory motifs in the human hematopoietic system.", Mol Syst Biol, vol. 10, pp. 741, 2014 Jul 15.
2012
Behdani, M., Zeinali S., Khanahmad H., Karimipour M., Asadzadeh N., Azadmanesh K., Khabiri A., Schoonooghe S., Anbouhi M. Habibi, Hassanzadeh-Ghassabeh G., et al., "Generation and characterization of a functional Nanobody against the vascular endothelial growth factor receptor-2; angiogenesis cell receptor.", Mol Immunol, vol. 50, issue 1-2, pp. 35-41, 2012 Feb.
2011
Stijlemans, B., Caljon G., Natesan S. Kumar A., Saerens D., Conrath K., Pérez-Morga D., Skepper J. N., Nikolaou A., Brys L., Pays E., et al., "High affinity nanobodies against the Trypanosome brucei VSG are potent trypanolytic agents that block endocytosis.", PLoS Pathog, vol. 7, issue 6, pp. e1002072, 2011 Jun.
Almeida-Souza, L., Asselbergh B., d'Ydewalle C., Moonens K., Goethals S., de Winter V., Azmi A., Irobi J., Timmermans J-P., Gevaert K., et al., "Small heat-shock protein HSPB1 mutants stabilize microtubules in Charcot-Marie-Tooth neuropathy.", J Neurosci, vol. 31, issue 43, pp. 15320-8, 2011 Oct 26.
Bockstal, V., Guirnalda P., Caljon G., Goenka R., Telfer J. C., Frenkel D., Radwanska M., Magez S., and Black S. J., "T. brucei infection reduces B lymphopoiesis in bone marrow and truncates compensatory splenic lymphopoiesis through transitional B-cell apoptosis.", PLoS Pathog, vol. 7, issue 6, pp. e1002089, 2011 Jun.
2010
Deschacht, N., De Groeve K., Vincke C., Raes G., De Baetselier P., and Muyldermans S., "A novel promiscuous class of camelid single-domain antibody contributes to the antigen-binding repertoire.", J Immunol, vol. 184, issue 10, pp. 5696-704, 2010 May 15.
De Vocht, C., Ranquin A., Van Ginderachter J., Vanhaecke T., Rogiers V., Van Gelder P., Versées W., and Steyaert J., "Polymeric nanoreactors for enzyme replacement therapy of MNGIE.", J Control Release, vol. 148, issue 1, pp. e19-20, 2010 Nov 20.
2009
De Vocht, C., Ranquin A., Willaert R., Van Ginderachter J. A., Vanhaecke T., Rogiers V., Versées W., Van Gelder P., and Steyaert J., "Assessment of stability, toxicity and immunogenicity of new polymeric nanoreactors for use in enzyme replacement therapy of MNGIE.", J Control Release, vol. 137, issue 3, pp. 246-54, 2009 Aug 4.
2007
Magez, S., Radwanska M., Drennan M., Fick L., Baral T. Nath, Allie N., Jacobs M., Nedospasov S., Brombacher F., Ryffel B., et al., "Tumor necrosis factor (TNF) receptor-1 (TNFp55) signal transduction and macrophage-derived soluble TNF are crucial for nitric oxide-mediated Trypanosoma congolense parasite killing.", J Infect Dis, vol. 196, issue 6, pp. 954-62, 2007 Sep 15.
2005
Drennan, M. B., Stijlemans B., Van Den Abbeele J., Quesniaux V. J., Barkhuizen M., Brombacher F., De Baetselier P., Ryffel B., and Magez S., "The induction of a type 1 immune response following a Trypanosoma brucei infection is MyD88 dependent.", J Immunol, vol. 175, issue 4, pp. 2501-9, 2005 Aug 15.
2000
Namangala, B., Brys L., Magez S., De Baetselier P., and Beschin A., "Trypanosoma brucei brucei infection impairs MHC class II antigen presentation capacity of macrophages.", Parasite Immunol, vol. 22, issue 7, pp. 361-70, 2000 Jul.
1998
Beschin, A., Brys L., Magez S., Radwanska M., and De Baetselier P., "Trypanosoma brucei infection elicits nitric oxide-dependent and nitric oxide-independent suppressive mechanisms.", J Leukoc Biol, vol. 63, issue 4, pp. 429-39, 1998 Apr.
1993
Magez, S., Lucas R., Darji A., Songa E. B., Hamers R., and De Baetselier P., "Murine tumour necrosis factor plays a protective role during the initial phase of the experimental infection with Trypanosoma brucei brucei.", Parasite Immunol, vol. 15, issue 11, pp. 635-41, 1993 Nov.